By Charles S. Alovisetti, Partner
Sep 9, 2019
The third post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post, we will focus on governance, exits, and investors.
By Charles S. Alovisetti, Partner
Sep 6, 2019
The second post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post, we will focus on taxation, audits, investments and other administrative headaches.
By Charles S. Alovisetti, Partner
Sep 6, 2019
The first post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post we will focus on entity choice and taxation.
By Charles S. Alovisetti, Partner; Jessica Scardina, Senior Associate Attorney; and Ben Leonard, Associate Attorney
Aug 26, 2019
New guidance from the Colorado MED clarifies that companies and investors can begin taking advantage of HB 1090’s more flexible regulatory structure immediately.
By Shawn Hauser, Partner; Michelle Bodian, Senior Associate Attorney; Caitlin Wightman, Law Clerk
Aug 23, 2019
Key takeaways from the U.S. Senate Agriculture Committee’s historic hearing on Thursday, July 25, 2019, where they discussed hemp production and related issues ahead of the release of federal rules.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.